文献速递淋巴瘤

惰性非霍奇金淋巴瘤幸存者中持续性疲劳、神经病变和角色功能受损症状:一项纵向PROFILES登记研究

Persistent symptoms of fatigue, neuropathy and role-functioning impairment among indolent non-Hodgkin lymphoma survivors: A longitudinal PROFILES registry study.
PubMed 文献 · Br J Haematol · 2022-04-02

该大型基于人群的纵向研究纳入1999至2014年确诊的惰性非霍奇金淋巴瘤患者,通过EORTC QLQ-C30和CLL-16问卷评估长期健康相关生活质量及症状持续性,669例患者完成问卷(应答率74%),平均完成4次问卷。结果显示36%报告持续性疲劳、33%持续性神经病变、25%持续性角色功能受损,为年龄性别匹配 normative 人群的2至3倍,确诊后10年内评分相对稳定无临床相关变化。

要点

  • 36%的惰性非霍奇金淋巴瘤患者报告持续性疲劳,33%报告持续性神经病变,25%报告持续性角色功能受损。
  • 上述症状发生率约为年龄和性别匹配 normative 人群的2至3倍,确诊后10年内评分相对稳定。
  • 合并症、心理困扰、确诊后时间较短、系统治疗、较年轻年龄、教育水平及无伴侣与更差结局相关(所有P值<0.05)。

核心结论

  • 多达三分之一的惰性非霍奇金淋巴瘤患者经历长期持续性症状,且随时间推移不改善。
  • 早期识别症状有助于为有需要的患者提供量身定制的支持性照护。

研究设计与样本

  • 大型基于人群的纵向研究,纳入1999年至2014年确诊且确诊后4个月及以上的惰性非霍奇金淋巴瘤患者。
  • 社会人口学和临床数据来自荷兰癌症登记处,669例患者完成EORTC QLQ-C30和CLL-16问卷(应答率74%),平均完成4次问卷。
  • 初始治疗为主动监测(52%)、系统治疗(31%)或放疗(13%)。

主要发现

  • 36%报告持续性疲劳,33%报告持续性神经病变,25%报告持续性角色功能受损。
  • 上述持续性症状发生率是年龄和性别匹配 normative 人群的2至3倍。
  • 确诊后长达10年评分保持相对稳定,无临床相关变化。
  • 合并症、心理困扰、确诊后时间较短、系统治疗、较年轻年龄、教育水平及无伴侣与更差结局相关(所有P值<0.05)。

临床怎么用

  • 早期识别症状有助于为有需要的惰性非霍奇金淋巴瘤患者提供量身定制的支持性照护。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Little is known about the long-term health-related quality of life (HRQoL) and persistence of symptoms among patients with indolent non-Hodgkin lymphoma (iNHL). This large population-based longitudinal study therefore investigated the long-term HRQoL and persistence of symptoms and identified associated sociodemographic, clinical and psychological factors. Patients diagnosed between 1999 and 2014 and four or more months after diagnosis were invited to participate in a longitudinal survey. Sociodemographic and clinical data were obtained from the Netherlands Cancer Registry. The EORTC QLQ-C30 and CLL-16 were completed by 669 patients (74% response rate). Patients completed on average four questionnaires. Primary treatment was active surveillance (52%), systemic therapy (31%) or radiotherapy (13%). Respectively, 36% reported persistent fatigue, 33% persistent neuropathy and 25% persistent role-functioning impairment. This was 2-3 times higher than in the age- and sex-matched normative population. Up to 10 years after diagnosis, scores remained relatively stable without clinically relevant changes. Comorbidities, psychological distress, shorter time since diagnosis, systemic therapy, younger age, education level and having no partner were associated with worse outcomes (all ps < 0.05). Up to a third of patients with iNHL experience long-term persistent symptoms which do not improve over time. Early recognition of symptoms will help in providing tailored supportive care for those in need.

来源:Br J Haematol,查看原文。版权归原作者所有。

引用

  1. Ekels A, van de Poll-Franse LV, Posthuma EFM, et al. Persistent symptoms of fatigue, neuropathy and role-functioning impairment among indolent non-Hodgkin lymphoma survivors: A longitudinal PROFILES registry study. Br J Haematol. 2022. PMID: 35365860. doi:10.1111/bjh.18139

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。